Randomized Trial of FOLFOX Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair or Microsatellite Instability (ATOMIC, Alliance A021502)
- Citation:
- J Clin Oncol vol 35 (15 suppl) abstr TPS3630
- Meeting Instance:
- ASCO 2017
- Year:
- 2017
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- FA Sinicrope F-S Ou Q Shi A Nixon Kabir Mody Alex LeVasseur Amylou Dueck Asha Dhanarajan Christopher Lie Deirdre Cohen Federico Innocenti Robert Behrens Walter Peters DJ Sargent N Sommers E O'Reilly J Meyerhardt
- Networks:
- IL017, IWORC, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NC010, LAPS-NY016, TX012
- Study
- Alliance-A021502
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: